Carson City, Nevada, January 30, 2018, Cell MedX Corp. (OTCQB: CMXC, 9CX:MUN), (“Cell MedX” or the “Company”), is an early development stage bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness.…
Carson City, Nevada, January 29, 2018, Cell MedX Corp. (OTCQB: CMXC; 9CX:MUN), (“Cell MedX” or the “Company”), announces that it has been assigned a Legal Entity Identifier number 967600RJ7LKTH79OWE67. About the Legal Entity Identifier Number (“LEI”) The European Union has…
Carson City, Nevada, January 24, 2018, Cell MedX Corp. (OTCQB: CMXC), (“Cell MedX” or the “Company”), an early development stage bio-tech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is pleased…